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Mouse models of autism can be used to study evolutionarily conserved mechanisms
underlying behavioral abnormalities in social communication and repetitive behaviors.
SHANK genes code for synaptic scaffolding proteins at excitatory synapses and
mutations in all SHANK genes have been associated with autism. Here, we present
three behavioral aspects of the mutant mice deleted for exon 16 in Shank2. First, we
treated Shank2 mutant mice with methylphenidate to rescue the hyperactivity. Our failure
to do so suggests that the hyperactivity displayed by Shank2 mutant mice is not related
to the one displayed by the typical mouse models of hyperactivity, and might be more
closely related to manic-like behaviors. Second, by testing the effect of group housing
and social isolation on social interest, we highlighted that Shank2 mutant mice lack
the typical flexibility to modulate social interest, in comparison with wild-type littermates.
Finally, we established a new protocol to test for social recognition in a social context. We
used this protocol to show that Shank2 mutant mice were able to discriminate familiar
and unknown conspecifics in free interactions. Altogether, these studies shed some light
on specific aspects of the behavioral defects displayed by the Shank2 mouse model.
Such information could be used to orient therapeutic strategies and to design more
specific tests to characterize the complex behavior of mouse models of autism.
Keywords: mouse models, autism, Shank2, hyperactivity, methylphenidate, social motivation, ultrasonic
vocalization, social recognition
INTRODUCTION
Autism spectrum conditions (ASCs; henceforth autism) are characterized by atypical social
communication, including social interactions and verbal and non-verbal communication, as well
as stereotyped and repeated behaviors and restricted interests (American Psychiatric Association,
2013). More than 80 genes have been robustly associated with autism (Abrahams et al., 2013).
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Among these genes, the SHANK family is of interest since
mutations in each of the three members of this family
(SHANK1, PROSAP1/SHANK2, and PROSAP2/SHANK3)
have been identified in patients with autism, but with
a gradient of severity (Leblond et al., 2014). Patients
carrying a mutation in SHANK1 display a mild phenotype
in social communication and stereotypes, while patients
carrying SHANK2 mutations are more affected in their
social interactions and repetitive behaviors. Patients with
SHANK3 mutations are even more severely affected and are
also in the great majority of cases diagnosed with intellectual
disability.
In the present study, we focused our experiments on mice
lacking the Shank2 protein. To date, three different genetic
constructions of the model exist (reviewed in Eltokhi et al., 2018):
deletion of exon 16 [knock out (Schmeisser et al., 2012; Ey et al.,
2013; Lim et al., 2016), conditional knock out in Purkinje cells
(Peter et al., 2016)], deletion of exons 15 and 16 [knock out (Won
et al., 2012; Lee et al., 2015; Lim et al., 2016), conditional knock
out in Purkinje cells (Ha et al., 2016), conditional knock out
in excitatory neurons (Kim et al., 2018), conditional knock out
in inhibitory neurons (Kim et al., 2018), conditional knock out
in parvalbumin-positive neurons (Lee et al., 2018)], deletion of
exon 24 [knock out (Pappas et al., 2017), conditional knock out
in Purkinje cells (Pappas et al., 2017), conditional knock out in
excitatory neurons of neocortex and hippocampus (Pappas et al.,
2017)]. All these models display hyperactivity, except the mice
mutated conditionally only in Purkinje cells (Ha et al., 2016; Peter
et al., 2016; Pappas et al., 2017). As proxies for the core symptoms
of autism, a number of studies identified subtle abnormalities
in the social domain [reduced interest for social interactions
(Schmeisser et al., 2012; Won et al., 2012; Lee et al., 2015; Peter
et al., 2016; Kim et al., 2018)] [but not in Ha et al. (2016); Lim
et al. (2016); Pappas et al. (2017); and Lee et al. (2018)], reduced
interest for social novelty (Schmeisser et al., 2012; Lee et al., 2015;
Peter et al., 2016) [but not in Won et al. (2012) and Kim et al.
(2018)], atypical ultrasonic communication (Schmeisser et al.,
2012; Won et al., 2012; Ey et al., 2013; Ha et al., 2016; Kim et al.,
2018), and increased stereotyped behaviors (Ha et al., 2016; Peter
et al., 2016; Kim et al., 2018; Lee et al., 2018) [but not in Lee et al.
(2015); Pappas et al. (2017); and Kim et al. (2018)].
In this study, we aimed at modulating the behavioral
phenotype of the Shank21ex16−/− [hereafter Shank2 (MGI:
5435698; Schmeisser et al., 2012)] mice using pharmacological
treatment or social isolation. For the pharmacological treatment,
we used methylphenidate (commercially available for medical
use under the name Ritalin R©), a treatment for individuals
diagnosed with attention-deficit/hyperactivity disorder (ADHD)
(Stepanova et al., 2017). To test for social interest, we
modulated the motivation to interact with another mouse
by including a period of social isolation prior to the social
interaction test. Finally, a review of the existing protocols
for social recognition in mice (see Supplementary Material –
Review of social recognition protocols) highlighted that the
habituation-dishabituation protocol was ethologically relevant.
We adapted this protocol by testing simultaneously the
mutant mouse and the wild-type mouse to control rigorously
the investigation of social recognition in Shank2 mutant
mice.
MATERIALS AND METHODS
Modulation Through Pharmacological
Treatment
We tested males (placebo: 10 Shank2+/+, 10 Shank2+/−, 10
Shank2−/−; treatment: 10 Shank2+/+, 10 Shank2+/−, and 10
Shank2−/−) and females (placebo: 9 Shank2+/+, 10 Shank2+/−,
10 Shank2−/−; treatment: 9 Shank2+/+, 10 Shank2+/−, 10
Shank2−/−) aged of 4–6 months. Female mice were housed
in groups of 2–4 per cage, while males were single-housed
because of high aggressiveness. Shank2 mutant mice were
initially described in Schmeisser et al. (2012), backcrossed
for more than 10 generations on C57Bl/6J. We injected the
animals with methylphenidate (MPH; 30 mg/kg; intra-peritoneal
injection) or saline solution, 1 h before the test. Whether mice
received saline or MPH was randomly chosen before starting
the experiment. We tested the animals in the openfield. One
hour after the injection, the animals were left to freely explore
a round openfield (1 m of diameter) for 30 min (100 lux). We
measured the distance traveled and compared it between wild-
type, Shank2+/− and Shank2−/− mice treated with either saline
solution or methylphenidate using non-parametric Wilcoxon-
Mann-Whitney U-tests given the small sample size and the
non-normal distribution of the data.
Modulation Through Social Isolation
We tested 16 Shank2+/+ and 13 Shank2−/− adult females of
4–6 months of age (Schmeisser et al., 2012). We did not use
Shank2+/− mice in the remaining parts of the paper, given the
subtlety of social defects in this genotype (Schmeisser et al.,
2012). Shank2+/+ and Shank2−/− mice were tested twice in
the occupant-new comer test (Ferhat et al., 2016). On the
first time, they were group-housed (2–4 mice per cage) from
weaning on. On the second time 3 weeks later, they were
isolated for 3 days before the test; this last data had been
presented in the original study (Schmeisser et al., 2012). In
the occupant-new comer test, a female mouse (occupant) was
placed in a test cage (Plexiglas, 50 cm × 25 cm × 30 cm,
100 lux, with fresh bedding) in a soundproof chamber for
30 min habituation. After this time, an unfamiliar group-
housed C57Bl/6J adult female (new comer) was introduced.
Social interactions were recorded continuously (high-resolution
Sony XCD-SX90CR video camera). Ultrasonic vocalizations
were recorded simultaneously with a condenser ultrasound
microphone Polaroid/CMPA, the interface UltraSoundGate 416-
200 and the software Avisoft-SASLab Pro Recorded from Avisoft
Bioacoustics (sampling frequency: 300 kHz; FFT-length: 1024
points; 16-bit format). Ultrasonic vocalizations were recorded for
the pair of mice tested (one C57Bl/6J new comer and one from
the Shank2 strain, either a wild-type one or a mutant one) since
we cannot distinguish the identity of the caller in such a setting.
Nevertheless, previous studies suggested that the contribution
of the new comer is minor in comparison with that of the
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occupant (Hammerschmidt et al., 2012). We recorded manually
the time spent in contact and the latency for the first contact.
We also measured manually the latency for the first ultrasonic
vocalizations and the total number of ultrasonic vocalizations
emitted. We manually established the distribution of ultrasonic
vocalizations among the following call types (see Ey et al., 2013):
- “short”: call duration was less than 5 ms;
- “simple”: call duration was longer than 5 ms and the
frequency range was smaller than 6.25 kHz (flat) or call
duration was longer than 5 ms and the frequency range was
larger than 6.25 kHz and there was only one direction of
frequency modulation (upward or downward);
- “complex”: frequency modulations in more than one
direction and frequency range larger than 6.25 kHz
(modulated), or inclusion of one or more additional
frequency components (harmonic or non-linear
phenomena, but no saturation) but no constraint on
frequency range (complex);
- “unstructured”: no pure tone component, “noisy” calls;
- “frequency jumps” (fq jumps): presence of one or more
jump(s) in frequency, without time gap between the
consecutive elements; it can include noisy parts within the
pure tone call or not.
We used unpaired non-parametric Wilcoxon tests to compare
the latency for the first contact, the total time spent in contact,
the latency for the first call and the call rate between genotypes
within the social condition (either grouped or isolated). We used
paired non-parametric Wilcoxon tests to compare the latency for
the first contact, the total time spent in contact, the latency for
the first call and the call rate between social conditions (grouped
or isolated) within genotypes. We used Chi-squared (with a
Bonferroni correction for multiple testing) tests to compare the
proportions of calls within and between social conditions or
genotypes.
New Protocol for Social Recognition
We set up a new habituation-dishabituation test. After
carefully reviewing the different protocols available to test
social recognition, we found three protocols using free social
interactions: two-trial social recognition, social discrimination,
habituation-dishabituation (see Supplementary Material –
Review of social recognition protocols). We adapted the
habituation-dishabituation protocol by testing a pair of female
mice (one Shank2+/+ mouse and one Shank2−/− mouse) with
a juvenile C57Bl/6J female mouse as the stimulus mouse. By
testing paired mice, we collected data from the mutant and
its control mouse in exactly the same conditions. We tested
12 pairs of one Shank2+/+ adult female and one Shank2−/−
adult female (6 months of age), paired together at least 1 week
before testing. Juvenile females were housed in groups of four
upon arrival at the animal facility (3 weeks of age) and until
the end of the experiment. Mice were identified through RFID
chips implanted under isoflurane anesthesia and after local
sub-cutaneous injection of lidocaine (at 4 weeks of age for the
juveniles and at weaning for the tested mice). On the day of
testing, mice were habituated to the testing room 20 min before
the test. We then introduced the pair of Shank2 mice in a test
cage (50 cm × 50 cm × 30 cm, fresh bedding). The pair of mice
was left to explore freely the test cage for 20 min. After this
habituation time, we introduced an unknown C57Bl/6J juvenile
female mouse (5 weeks of age) and let the mice freely interact
for 2 min. After this first encounter, we took out of the cage the
juvenile mouse and left it alone in a housing cage for 5 min. We
then re-introduced it in the cage for 2 min. We repeated these
steps for four encounters with the same juvenile. On the fifth
encounter, we introduced another unknown C57Bl/6J juvenile
female mouse (5 weeks of age) from another housing cage.
During each encounter, a tracking system, Live Mouse Tracker,
allowed to individually follow each of the three mice and to
automatically extract the time spent in contact with the juvenile
for each tested mouse (de Chaumont et al., 2018). We used
unpaired non-parametric Wilcoxon tests to compare the total
time spent in contact.
We used paired non-parametric Wilcoxon tests to compare
the total time spent in contact between Shank2+/+ and
Shank2−/− mice (within each pair) for each juvenile encounter.
We used paired non-parametric Wilcoxon tests to compare the
total time spent in contact within each genotype between the
fourth encounter and the fifth one.
Ethic Approval Statement
All experiments involving animals complied with the European
ethical regulation, and were validated by the ethical committee
CETEA n◦89, Institut Pasteur, Paris. These procedures were
realized within the project APAFIS#7706-20 161 12317252460 v2.
RESULTS
The Effects of Methylphenidate on
Hyperactivity in Shank2 Mutant Mice
Shank2−/− mice are highly hyperactive in comparison with
their wild-type littermates (Schmeisser et al., 2012). Here, we
injected adult males and females with methylphenidate (MPH)
or saline solution, 1 h before the openfield test. The saline-
injected Shank2−/− mice traveled significantly longer distances
in comparison with saline-injected Shank2+/+ mice (males:
W = 0, p < 0.001; females: W = 10.5, p = 0.005) and
Shank2+/− mice (males: W = 7, p < 0.001; females: W = 0,
p < 0.001; Figure 1). In addition, Shank2+/− mice also
displayed hyperactivity but to a lower extend in comparison
with their wild-type littermates (males: W = 21.5, p = 0.034;
females: W = 0, p < 0.001). These results confirmed the
initially described gene dosage-related hyperactivity in this
model (Schmeisser et al., 2012). MPH treatment increased
significantly the distance traveled by Shank2+/+ mice (males:
W = 10, p = 0.003; females: W = 4.5, p = 0.002) and by
Shank2+/− mice (males: W = 10, p = 0.002; females: W = 5,
p < 0.001) in comparison with saline-injected mice of the same
genotypes in both sexes. The MPH treatment also increased
significantly the distance traveled by Shank2−/− female mice
in comparison with saline-injected Shank2−/− female mice
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FIGURE 1 | Similar enhancement of activity by methylphenidate treatment in Shank2 wild-type and mutant mice. Distance traveled in 30-min free exploration of an
openfield in (A) male and in (B) female Shank2+/+ (blue), Shank2+/− (gray) and Shank2−/− (orange) mice after methylphenidate treatment (MPH, 30 mg/kg) or after
saline injection 1 h before the test. Data are presented as mean ± SEM, with individual points. Uncorrected non-parametric Wilcoxon tests were used (∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001).
(W = 14, p = 0.005; Figure 1B). The difference in Shank2−/−
male mice in comparison with saline-injected Shank2−/− males
was not significant (W = 36, p = 0.307; Figure 1A), but
the hyperactivity was already very high and we might have a
saturation effect. In both sexes, MPH-injected Shank2−/− mice
still traveled significantly longer distances in comparison with
MPH-injected Shank2+/+mice (males:W = 8, p = 0.002; females:
W = 2, p< 0.001).
Overall, Shank2−/−, Shank2+/−, and Shank2+/+ mice
reacted similarly to the injection of MPH, with an increase in
their locomotor activity. MPH was therefore not efficient to
rescue hyperactivity in this model.
The Effects of Social Isolation on Social
Behavior in Shank2 Mutant Mice
Many mouse models of autism display only subtle abnormalities
in classical behavioral tests for social interest (reviewed in Ferhat
et al., 2017). One hypothesis is that the main social problem might
reside in the social reward system, which can impair behavioral
flexibility [see for instance the lack of social modulation of
ultrasonic vocalizations in Shank1 mutant mice (Wöhr et al.,
2011)].
In this study, we therefore compared social interactions and
ultrasonic vocalizations in the occupant-new comer test between
group-housed and isolated adult female mice from the Shank2
mutant strain. When females were group-housed, there were no
significant differences between Shank2+/+ mice and Shank2−/−
mice in the latency for the first contact (W = 120.5, p = 0.482;
Figure 2A), in the time spent in contact (W = 98.5, p = 0.826;
Figure 2B), in the latency for the first call (W = 95, p = 0.714;
Figure 2C), and in the vocal repertoire used (Figures 3A,B).
The only difference was found in the number of vocalizations
emitted, with less vocalizations emitted by Shank2−/− mice
in comparison with wild-type mice (W = 150, p = 0.046;
Figure 2D).
When females were isolated for 3 days, Shank2−/− mice
spent significantly shorter time in contact with the new
comer (W = 165, p = 0.008; Figure 2B) and emitted less
ultrasonic vocalizations in comparison with Shank2+/+ mice
(W = 171, p = 0.003; Figure 2D). Interestingly, when considering
the ultrasonic vocalization repertoire used, Shank2−/− mice
emitted significantly more calls from the short and unstructured
categories than Shank2+/+ mice in the isolated condition
(Figures 3A,B). In contrast, the duration of the calls for each
call type did not differ significantly between social conditions or
between genotypes (Figures 3C,D).
Overall, significant differences in social interaction and
communication emerged between Shank2−/− and Shank2+/+
mice only after social isolation, and not when animals were
group-housed. These results suggested that Shank2−/− mice
were impaired in their modulation of social motivation.
Social Recognition in a Social Context in
Shank2 Mutant Mice
In their initial characterization, Shank2−/− female mice
displayed impairments in social recognition in the three-
chambered test, with no significant preference for an unknown
conspecific in comparison with a familiar conspecific (Schmeisser
et al., 2012; Peter et al., 2016). However, in other studies using the
Shank21ex15−16 mice, social recognition in the three-chambered
test did not differ significantly between homozygous mutant and
wild-type (Won et al., 2012; Lee et al., 2015; Kim et al., 2018). In
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FIGURE 2 | Previous social isolation modulates social communication in wild-type female mice but not in Shank2 mutant female mice. In the 4-min (i.e., 240 s)
occupant-new comer test, the latency to establish the first contact (A), the total time spent in contact (B), the latency to emit the first ultrasonic vocalization (C) and
the number of calls per minute (D) were measured in group-housed mice and in mice isolated for 3 days before testing. Data are presented as mean ± SEM, with
individual points. Uncorrected non-parametric Wilcoxon tests were used (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001).
the present study, we aimed at testing whether social recognition
was impaired when mice were freely interacting. We established
a habituation-dishabituation test with a pair of adult female mice
(one Shank2+/+ mouse and one Shank2−/− mouse, familiar
to each other for at least 1 week before the test) interacting
repeatedly with a C57Bl/6J juvenile female. After four encounters
with the same juvenile, the pair of mice encountered an unknown
juvenile on the fifth encounter.
The social recognition protocol appeared to be valid. Indeed,
the time that Shank2+/+ mice spent in contact with the juvenile
decreased over the four successive expositions to the same
juvenile (Figure 4, blue line and dots). Then, they spent a
significantly increased time in contact with the second juvenile
presented for the fifth encounter (W = 1, p = 0.002), suggesting
that they were able to discriminate their juvenile conspecifics.
Shank2−/− mice followed a parallel profile despite the fact that
they tended to spend shorter time in contact with the juveniles
in comparison with their wild-type littermates (encounter 2:
W = 65, p = 0.042; encounter 3: W = 66, p = 0.034; encounter
5: W = 65, p = 0.042; Figure 4, orange line and dots). As in
Shank2+/+ mice, the time that Shank2−/− mice spent in contact
with the juvenile between the fourth and the fifth encounters also
increased significantly (W = 0, p< 0.001).
Overall, the Shank2−/− mice spent shorter time in contact
with the juvenile in comparison with wild-type mice but
remained able to differentiate two individuals.
DISCUSSION
Methylphenidate Does Not Rescue the
Hyperactivity of the Adult Shank2−/−
Mice
The psychostimulant methylphenidate inhibits the reuptake
of dopamine and norepinephrine (increase of dopamine and
norepinephrine extracellular levels) (de la Peña et al., 2018). It
is known to be an effective treatment for a subset of patients
diagnosed with hyperactivity in humans (reviewed in Stepanova
et al., 2017). It appeared to improve inattention, distractibility,
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FIGURE 3 | Effects of social isolation on the repertoire and duration of ultrasonic vocalizations emitted by Shank2 females. Distribution of ultrasonic vocalizations
among the five call types recorded during same-sex social interactions (4 min, i.e., 240 s) in group-housed females (A) and in females isolated for 3 days (B). Mean
duration of the five call types recorded during same-sex social interactions in group-housed females (C) and in females isolated for 3 days (D). Data are presented as
mean ± SEM, with individual points. Uncorrected Chi-squared tests were used to compare the proportion of each call type between pairs involving one wild-type
and pairs involving one Shank2 mutant mice within a social condition (∗p < 0.05, ∗∗p < 0.01) or between social condition (either grouped or isolated) within one
genotype (#p < 0.05).
hyperactivity and impulsivity more efficiently than placebo in
patients with autism or neurodevelopmental disorders (Quintana
et al., 1995; Handen et al., 2000; Research Units on Pediatric
Psychopharmacology Autism Network, 2005; Kim et al., 2017).
For instance, in a large study conducted by the Research Units
on Pediatric Psychopharmacology Autism Network, about half
of the patients with autism or neurodevelopmental disorders and
hyperactivity responded to methylphenidate treatment (Research
Units on Pediatric Psychopharmacology Autism Network, 2005).
Nevertheless, methylphenidate appeared to be less efficient and
to present more adverse effects (e.g., social withdrawal) in
patients with autism than in children developing typical ADHD
(Research Units on Pediatric Psychopharmacology Autism
Network, 2005; Stepanova et al., 2017). Methylphenidate also
tended to increase social withdrawal in patients with ADHD
(Research Units on Pediatric Psychopharmacology Autism
Network, 2005).
In mice, methylphenidate is used to test the predictive
validity of mouse models for ADHD, since it can rescue the
hyperactivity of several of these mouse models (de la Peña
et al., 2018). In mouse models of autism, methylphenidate
did not rescue hyperactivity in Fmr1−/− mice (Wrenn et al.,
2015). In the first part of the present study, we highlighted
that an injection of methylphenidate increased the activity
of Shank2+/+ mice, as expected in wild-type mice, but also
increased the activity of Shank2+/− and Shank2−/− mice. These
results show that the hyperactivity of Shank2−/− adult mice is
not attenuated by methylphenidate, and therefore might not be
related to “ADHD-like hyperactivity.” Our results are consistent
with those from Pappas et al. (2017) who also observed an
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FIGURE 4 | Unaffected social recognition in Shank2 female mice. In the five
repeated exposures (2 min, i.e., 120 s; inter-trial interval: 1 min, i.e., 60 s) of a
pair of one Shank2+/+ mouse and one Shank2−/− mouse to an unknown
juvenile, the time spent in contact with the juvenile was measured for each
tested mouse. The juvenile introduced was the same in encounters one to
four; on encounter five, a new juvenile was introduced. Data are presented as
mean ± SEM, with individual points. Uncorrected non-parametric paired
Wilcoxon tests were used (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001).
increased hyperactivity in Shank21ex24 mutant mice treated with
amphetamine (2 mg/kg), while this hyperactivity was rescued by
the mood stabilizers valproic acid or lithium (Pappas et al., 2017).
These results suggest that the hyperactive phenotype in Shank2
mutant mice could therefore be reminiscent of the manic-like
phenotype of a mouse model for bipolar disorder. To further
investigate this parallel with manic-like behavior, future studies
on Shank2 mouse models should include analyses on sleep-wake
cycles, impulsivity and preference for reward stimuli (Beyer and
Freund, 2017). Investigating the dopaminergic pathway in this
model might also provide information on the relatedness of the
phenotype of Shank2 mice with a manic-like phenotype. With
preliminary data in an eight-arm radial maze for spatial learning,
we already noticed an increased arousal of Shank2−/− mice
when seeking for the sweet reward in comparison with their
wild-type littermates (unpublished data), suggesting an atypical
reward seeking behavior. In parallel, clioquinol, a zinc chelator
and a ionophore mobilizing trans-synaptic zinc has been shown
to rescue the reduced social interest in the three-chambered test
in mouse models of autism, but could not rescue the hyperactivity
observed in the Shank21ex15−16 model (Lee et al., 2015).
Prior Isolation Increases Social
Motivation for Conspecific, but Not in the
Shank2−/− Mice
A reduction of social interactions might originate from
abnormalities in the neuronal circuits involved in social reward.
The strength of social interactions might then be modulated
by the motivation of the individual to interact with peers. We
aimed at testing whether mice lacking Shank2 have the ability
to modulate their interest in social interactions. We therefore
manipulated their motivation to interact by housing them in
groups or isolated.
While wild-type Shank2+/+ mice housed in isolation
increased their social motivation with more time spent in
contact and higher call rate compared to the group-housed
condition, Shank2−/− mutant mice behaved similarly, no matter
whether in the isolated or group-housed conditions. Their level
of behavioral flexibility in the social domain appeared to be
lower in comparison with wild-type mice. Unfortunately, this
mouse model has never been tested in a reversal learning task,
to assess its cognitive flexibility. Other Shank2 mouse models
were tested for learning and memory but not in a reversal
learning task, except the conditional, parvalbumin cell-type
specific Shank21ex15−16 knock-out mice that displayed typical
learning and reversal learning in the Morris water maze task
(Lee et al., 2018). Therefore, the cognitive flexibility of Shank2
mutant mice remains to be further documented to understand
whether the present lack of social flexibility is related to a reduced
cognitive flexibility.
We could also hypothesize that Shank2−/− mice might
consider social interactions as more aversive and therefore less
rewarding than wild-type Shank2+/+ mice do. Indeed, our
previous work showed that Shank2−/− mice emit ultrasonic
vocalizations with lower peak frequency in comparison with
wild-type littermates (Ey et al., 2013). Interestingly, ultrasonic
vocalizations emitted by adult males usually displayed a lower
peak frequency in an aversive context (contention stress) than
in affiliative social interactions (Chabout et al., 2012). Further
experiments will focus on the modulation of the spontaneous
home cage behavior between Shank2−/− and Shank2+/+
mice to gather robust data on a more complete behavioral
repertoire. Long-term group studies are now possible using
a newly developed tracking system, Live Mouse Tracker (de
Chaumont et al., 2018). The first experiments with mixed-
genotype groups suggest that Shank2−/− female mice and their
wild-type littermates differ in their involvement in complex social
configurations (de Chaumont et al., 2018).
This reduced social reward could be in line with the hypothesis
reviewed by Chevallier et al. (2012), in which social deficits in
autism might come from social motivation deficits and therefore
trigger social cognition deficits, and not the reverse. However,
such an approach is still under discussion since evidences are
mixed (reviewed in Bottini, 2018).
Shank2−/− Mice Are Able to Integrate
Social Cues for Recognition of
Conspecific
The three-chamber test provides a binary way to measure the
preference for social novelty versus social familiarity: it is a yes/no
test (Crawley, 2004). It does not permit to disentangle whether
the animal has a reduced motivation for (i.e., is not interested in)
social novelty or whether it cannot distinguish the two different
mice presented. The paradigm presented here tried to distinguish
these two possibilities.
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We showed that Shank2−/− mice might be less motivated to
interact with an unknown conspecific since they tend to spend
shorter time in contact with the juvenile in comparison with
their wild-type littermates. Nevertheless, they did not display
social recognition impairments in this protocol: they still manage
to gather information about the identity of the conspecific.
Shank2−/− mice therefore are able to differentiate individuals
from one another, i.e., to perceive and analyze social cues.
This is reminiscent of a series of experiments conducted in
patients with autism. During social scene observation, toddlers
with autism are less focused on eyes in comparison with
neurotypical toddlers (Constantino et al., 2017), but they can be
faster at identifying facial information compared with typically
developed individuals (Gharib et al., 2015).
Whether the behavior of the Shank2−/− mouse is influenced
by the behavior of its paired wild-type conspecific is unknown. If
there were an influence of the behavior of the Shank2+/+ mouse
on the Shank2−/− mouse, this would mean that Shank2−/− mice
have the ability to socially imitate its paired conspecific, which
depicts some interesting social competencies. If Shank2−/− mice
behave totally independently from the paired Shank2+/+ mice,
this would mean that Shank2−/− mice own social recognition
ability. To disentangle these two possibilities, it would be
interesting to try this protocol of social recognition with different
types of pairings (Shank2−/− vs. Shank2−/−, Shank2−/− vs.
Shank2+/+, and Shank2+/+ vs. Shank2+/+) and also with
isolated mice.
CONCLUSION
To summarize, the present study gathers new pieces of
information on specific aspects of the behavior of the Shank2−/−
mice. It shows that the hyperactivity displayed by this model
cannot be reduced by methylphenidate. It also highlights that
the social deficits displayed by this model might stem from a
lack of flexibility in the social motivation. Finally, it provides
more details on the social recognition deficits, which were
not visible during direct social interactions with a conspecific,
i.e., when the tested mice had access to all identity cues of
the conspecifics. Interestingly, the reduced social interaction
displayed by Shank2−/− mice might therefore be misinterpreted
as a problem in social cognition. We propose an alternative
hypothesis that Shank2−/− mice have high capacity to integrate
social cues, but once these social cues are integrated, the mice
display less social motivation to interact. Such information could
be used to orient therapeutic strategies and to design more
specific behavioral tests to characterize mouse models of autism.
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